Impact of COVID-19 on the Onset and Progression of Alzheimer's Disease and Related Dementias: A Roadmap for Future Research.
COVID-19 causes lasting neurological symptoms in some survivors. Like other infections, COVID-19 may increase risk of cognitive impairment. This perspective highlights four knowledge gaps about COVID-19 that need to be filled to avoid this possible health issue. The first is the need to identify the COVID-19 symptoms, genetic polymorphisms and treatment decisions associated with risk of cognitive impairment. The second is the absence of model systems in which to test hypotheses relating infection to cognition. The third is the need for consortia for studying both existing and new longitudinal cohorts in which to monitor long term consequences of COVID-19 infection. A final knowledge gap discussed is the impact of the isolation and lack of social services brought about by quarantine/lockdowns on people living with dementia and their caregivers. Research into these areas may lead to interventions that reduce the overall risk of cognitive decline for COVID-19 survivors.
['Gordon|Marcia N|MN|', 'Heneka|Michael T|MT|', 'Le Page|Lydia M|LM|', 'Limberger|Christian|C|', 'Morgan|David|D|https://orcid.org/0000-0003-1224-7476', 'Tenner|Andrea J|AJ|', 'Terrando|Niccolò|N|', 'Willette|Auriel A|AA|', 'Willette|Sara A|SA|']
COVID-19 longitudinal cohort Alzheimer's risk factor SARS-CoV-2 caregiver burden delerium systemic inflammation